Zions Bancorporation N.A. Purchases 303 Shares of Centene Co. (NYSE:CNC)

Zions Bancorporation N.A. increased its position in Centene Co. (NYSE:CNC) by 14.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,330 shares of the company’s stock after buying an additional 303 shares during the quarter. Zions Bancorporation N.A.’s holdings in Centene were worth $175,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the business. Park Place Capital Corp raised its stake in shares of Centene by 1,190.0% during the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock valued at $29,000 after acquiring an additional 357 shares during the last quarter. WR Wealth Planners LLC lifted its holdings in Centene by 41.4% during the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after buying an additional 137 shares during the period. Chris Bulman Inc acquired a new stake in shares of Centene in the second quarter valued at about $33,000. Riverview Trust Co raised its position in shares of Centene by 154.6% during the second quarter. Riverview Trust Co now owns 527 shares of the company’s stock worth $35,000 after acquiring an additional 320 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. bought a new stake in Centene in the second quarter valued at approximately $36,000. Institutional investors own 93.63% of the company’s stock.

Centene Stock Down 2.1 %

CNC stock opened at $57.45 on Friday. The stock’s 50 day moving average is $68.33 and its 200-day moving average is $71.12. Centene Co. has a twelve month low of $57.25 and a twelve month high of $81.42. The firm has a market capitalization of $29.00 billion, a PE ratio of 9.97, a P/E/G ratio of 0.80 and a beta of 0.49. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on CNC. Barclays dropped their price target on shares of Centene from $97.00 to $91.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 29th. Wells Fargo & Company decreased their price target on Centene from $91.00 to $90.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Oppenheimer cut their target price on Centene from $110.00 to $95.00 and set an “outperform” rating on the stock in a research report on Monday, July 29th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 target price on shares of Centene in a report on Tuesday, October 1st. Finally, Jefferies Financial Group downgraded shares of Centene from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $83.00 to $69.00 in a research report on Wednesday, July 24th. Seven research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, Centene has a consensus rating of “Moderate Buy” and a consensus target price of $83.92.

Insider Activity at Centene

In related news, CFO Andrew Lynn Asher purchased 17,200 shares of the business’s stock in a transaction that occurred on Wednesday, November 13th. The shares were bought at an average cost of $58.14 per share, with a total value of $1,000,008.00. Following the acquisition, the chief financial officer now owns 486,847 shares of the company’s stock, valued at $28,305,284.58. This represents a 3.66 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Sarah London bought 4,117 shares of the company’s stock in a transaction on Friday, November 8th. The stock was bought at an average price of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the purchase, the chief executive officer now owns 667,229 shares of the company’s stock, valued at approximately $40,567,523.20. The trade was a 0.62 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.33% of the stock is owned by insiders.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.